Policies & Guidance




Important Note:
UCLA is in the process of seeking accreditation of its Human Research Protection Program from the Association for the Accreditation of Human Research Protection Programs (AAHRPP). The policies and procedures listed below have been submitted to AAHRPP for review.

These policies and procedures are in effect, but may undergo revision as UCLA progresses through the accreditation process. Some items are currently unavailable as they undergo review by counsel.

The text of any Federal regulation cited in these policies may be found using the Electronic Code of Federal Regulations (e-CFR).

The text of any California law cited in these policies may be found using the Official California Legislative Information website.


UCLA OPRS/IRB Policies

The IRB/OPRS Policy Compilation (a 3 Mb searchable PDF file) includes all the individual policies listed below.


Policy #TitleLast Revised
1 Human Subject Research Overview July 5, 2007
2 Activities Subject to UCLA IRB/OPRS Jurisdiction July 5, 2007
3 Human Subject Research Determinations July 5, 2007
4 Research Conducted by UCLA Students July 5, 2007
5 OPRS Review Process - Certification of Exemption from IRB Review July 5, 2007
6 IRB Review Process - Initial Review July 5, 2007
7 Materials Required for IRB Review July 5, 2007
8 IRB Review Process - Expedited Review February 11, 2008
9 IRB Review Process - Full Committee Review July 5, 2007
10 IRB Review Process - Continuing Review July 5, 2007
11 IRB Review of Modifications to Previously Approved Research July 5, 2007
12 IRB Review Process - Communication of IRB Actions February 12, 2008
13 IRB Review Process - Executive Committee July 5, 2007
14 IRB Process: Administrative Acceptance Review and Administrative Approval July 5, 2007
15 Biomedical Adverse Event Reporting July 6, 2006
16 IRB Process - Consultant Review July 5, 2007
17 Study Closure July 5, 2007
18 Approvals From Other Committees July 5, 2007
19 IRB Review Requirements July 5, 2007
20 Special Considerations for Projects Involving Vulnerable Populations July 5, 2007
21 Special Subject Populations: Children July 5, 2007
22 Special Subject Populations: Pregnant Women, Human Fetuses, and Neonates July 5, 2007
23 Special Subject Populations: Prisoners July 5, 2007
24 Special Subject Populations: Cognitively Impaired July 5, 2007
25 Special Subject Populations: Students and Employees July 5, 2007
26 Special Subject Populations: Non-English Speaking Subjects July 5, 2007
27 Third Party Subjects (a.k.a., Secondary Subjects) July 5, 2007
28 Subject Pools July 5, 2007
29 Informed Consent Process and Documentation February 11, 2008
30 Recruitment Methods & Tools July 5, 2007
31 Payment for Participation in Research July 5, 2007
32 Financial Obligations July 5, 2007
33 Emergency Care and Compensation for Injury July 5, 2007
34 FDA Requirements February 11, 2008
35 IRB Approved Research in an Emergency Setting February 11, 2008
36 Emergency Use of a Test Article February 11, 2008
37 Genetics Research July 27, 2007
38 Human Embryonic Stem Cell Research July 5, 2007
39 Research Involving Use of Human Specimens, and Specimen Banking July 5, 2007
40 Data Repositories (a.k.a., "Banks") July 5, 2007
41 Research Involving Secondary Use of Existing Data July 5, 2007
42 Research Involving Public Use Data Files June 17, 2008
43 Data Security Guidelines July 5, 2007
44 Research Involving the Internet July 5, 2007
45 Research Involving Multiple Performance Sites or Collaborating Agencies or Institutions February 11, 2008
46 Research Conducted in International Settings July 5, 2007
47 Family Educational Rights and Privacy Act (FERPA) July 5, 2007
48 Protection of Pupil Rights Amendment (PPRA) July 5, 2007
49 Health Insurance Portability and Accountability Act (HIPAA)  
50 Special State Laws: Minor Subjects  
51 Reporting Suspected Abuse of Children, Elderly Individuals, and Others July 5, 2007
52 Reporting of Diseases and Conditions Identified in the Course of Research July 5, 2007
53 Noncompliance July 27, 2007
54 Consent Monitoring July 5, 2007
55 Protocol Violations July 27, 2007
56 Incident Reporting July 27, 2007
57 Unanticipated Problems Involving Risks to Subjects or Others July 6, 2006
58 Subject Complaints July 27, 2007
59 Suspension and Termination of Research July 27, 2007
60 Reporting Procedures For Unanticipated Problems, Suspension, or Termination July 27, 2007
61 Investigator Responsibilities July 27, 2007
62 Investigator and Key Personnel Training July 5, 2007
63 Investigator Financial Interests and Conflicts of Interest July 5, 2007
64 IRB Staff Training July 5, 2007
65 IRB Membership July 5, 2007
66 IRB Member Training July 5, 2007
67 IRB Member Conflict of Interest July 5, 2007
68 IRB Meeting Administration July 5, 2007
69 IRB Meeting Minutes July 5, 2007
70 IRB Office Records February 11, 2008
71 Media Interviews July 5, 2007


UCLA OPRS/IRB Guidance

TopicLast Revised
Adverse Events (Biomedical) April 1, 2005
Certificate of Confidentiality November 14, 2007
Data Banking  
Disclosure of Financial Interests February 20, 2007
Emergency Care and Compensation for Injury March 16, 2006
Fees for Reviews of Industry-Sponsored Clinical Trials 2002
Gift Policy and Human Subjects Research April 6, 2004
HIPAA May 2005
HIV Reporting July 6, 2006
Incident Reports (General)  
International Research Checklist - For Researchers June 2, 2008
Multisite Research May 26, 2006
Navy-Supported Research June 6, 2007
Oral History December 10, 2003
Proxy Informed Consent November 25, 2002
Screening Research Subjects October 7, 2001
Suicide Risk and Research Protocols May 26, 2006
Tissue Banking 2005
UCLA/RAND Memorandum of Understanding August 29, 2006


Other Policy Links

Policy Links
Research Advisory Panel of California (Office of the Attorney General)
UC HIPAA Research Policy
UC Research Policies & Guidelines
UCLA Administrative Policies & Procedures Manual (Section 900: Research & Instruction)
UCLA Biosafety
UCLA Conflict of Interest in Research
UCLA Office of Contract and Grant Administration
UCLA Radiation Safety
UCLA Stem Cell Applications & Documents